Evidence map›Paper›PMID 35890025›Full record

ArticlePathogens (Basel, Switzerland)2022

From Alpha to Delta-Genetic Epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland.

Emilia Morawiec, Maria Miklasińska-Majdanik, Jolanta Bratosiewicz-Wąsik, Robert D Wojtyczka, Denis Swolana, Ireneusz Stolarek, Michał Czerwiński, Aleksandra Skubis-Sikora, Magdalena Samul, Agnieszka Polak and 5 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Dominance of toxigenicFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emilia MorawiecDepartment of Microbiology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800 Zabrze, Poland.ORCID 0000-0002-8360-359X
Maria Miklasińska-MajdanikDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.ORCID 0000-0002-8607-8866
Jolanta Bratosiewicz-WąsikDepartment of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.
Robert D WojtyczkaDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.ORCID 0000-0002-0334-0938
Denis SwolanaDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.ORCID 0000-0002-5508-7567
Ireneusz StolarekDepartment of Molecular and Systems Biology, Institute of Bioorganic Chemistry Polish Academy of Sciences, 61-704 Poznań, Poland.
Michał CzerwińskiGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.ORCID 0000-0001-8931-3182
Aleksandra Skubis-SikoraGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.ORCID 0000-0002-3105-3055
Magdalena SamulGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.ORCID 0000-0002-2731-1779
Agnieszka PolakGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.
Celina Kruszniewska-RajsGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.
Adam PudełkoGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.
Marek FiglerowiczDepartment of Molecular and Systems Biology, Institute of Bioorganic Chemistry Polish Academy of Sciences, 61-704 Poznań, Poland.
Anna Bednarska-CzerwińskaGyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland.ORCID 0000-0001-9871-7082
Tomasz J WąsikDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.ORCID 0000-0001-6525-9767

Funding

Marshal's Office of the Silesian Voivodeship, EU funds from the Regional Operational Program of the Silesian Voivodeship UDA-RPSL.10.01.00-24-030H/20-02Medical University of Silesia in Katowice. Poland PCN-1-142/N/1/I
6 · The paper itself

Abstract

In Poland, the first case of SARS-CoV-2 infection was confirmed in March 2020. Since then, many circulating virus lineages fueled rapid pandemic waves which inflicted a severe burden on the Polish healthcare system. Some of these lineages were associated with increased transmissibility and immune escape. Mutations in the viral spike protein, which is responsible for host cell recognition and serves as the primary target for neutralizing antibodies, are of particular importance. We investigated the molecular epidemiology of the SARS-CoV-2 clades circulating in Southern Poland from February 2021 to August 2021. The 921 whole-genome sequences were used for variant identification, spike mutation, and phylogenetic analyses. The Pango B.1.1.7 was the dominant variant (n = 730, 89.68%) from March 2021 to July 2021. In July 2021, the B.1.1.7 was displaced by the B.1.617.2 lineage with 66.66% in July 2021 and 92.3% in August 2021 frequencies, respectively. Moreover, our results were compared with the sequencing available on the GISAID platform for other regions of Poland, the Czech Republic, and Slovakia. The analysis showed that the dominant variant in the analyzed period was B.1.1.7 in all countries and Southern Poland (Silesia). Interestingly, B.1.1.7 was replaced by B.1.617.2 earlier in Southern Poland than in the rest of the country. Moreover, in the Czech Republic and Slovakia, AY lineages were predominant at that time, contrary to the Silesia region.

Indexed as

molecular epidemiologyphylogeneticsPolandSARS-CoV-2 variantsspike mutationsviral genomicswhole-genome sequencing

Identifiers

PMID35890025
PMCPMC9316897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.